Ester Gea-Mallorquí (@estergeama) header
Ester Gea-Mallorquí (@estergeama) profile picture

I still like viruses 🦠👩🏽‍🔬🔬in love with DCs🫶🏼 Postdoc @NDMOxford | PhD @institut_curie | Tweets are in Catalan, English, French or Spanish. 📸🏔️📖🧵🌷🥐

Joined January 2011
Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)Photo by Ester Gea-Mallorquí (@estergeama)
🙌Check our latest #Review 👀 📚 We dissect the nature of DC-targeting lentivectors and their induced immune responses to help identify the knowledge gaps of one of the most promising and powerful tools for immunotherapy 👇💥💉
🆕 DC-targeting #lentivectors for cancer #immunotherapy This comprehensive review from @estergeama & @sarahlrj explores the world of lentivectors in #InVivo immunotherapy, with a special focus on #DendriticCell targeting 👉bit.ly/3SLqUxG
2
7
18
8,453
Ester Gea-Mallorquí retweeted
Online now: Tumor-to-dendritic cell reprogramming induces immunogenic lymphoid structures across cancers dlvr.​it/TWBfLG
1
25
2
99
5,160
Ester Gea-Mallorquí retweeted
This was the equivalent of extending human lifespan by 9 years science.org/content/article/… @ScienceMagazine
Bone as a modulator of aging. Dynamic force on the tibia is sensed and extends healthspan and lifespan, with reduced inflammation, and bone marrow immunosenescence in the experimental model. When Piezo1 (pressure sensor) receptor was deleted, resulting in lack of sensing, the opposite occurred @Cell_Metabolism sciencedirect.com/science/ar…
24
78
9
383
45,353
Ester Gea-Mallorquí retweeted
We're unable to measure our immune system status in the clinic. But that is about to change. Our @nature piece today, w/ @HugoAerts @nbirkbak @TsangLab nature.com/articles/d41586-0…
41
217
24
869
67,561
Ester Gea-Mallorquí retweeted
#ScienceSaturday 🧬 What if we could help the immune system’s cancer-fighting T cells regain their ability to attack tumors, even after they become exhausted? 🔬 New research published in Nature identifies a potential way to do just that. Scientists found that targeting a protein called ZMYND8 can restore signaling pathways that help CD8+ T cells maintain their cancer-killing abilities, rather than progressing toward a more dysfunctional state. 🛡️ Why does this matter? T-cell exhaustion is a major challenge in cancer #immunotherapy. When T cells are exposed to persistent signals from cancer cells, they can gradually lose their ability to mount an effective attack. Researchers found that removing ZMYND8’s inhibitory influence strengthened IL-2 signaling, which helps support T-cell activity and function. 💡 The findings are especially promising because targeting ZMYND8 enhanced antitumor activity in preclinical models, particularly when combined with IL-2 therapy or immune checkpoint blockade. The researchers also observed improvements in human T cells in laboratory studies, offering insight into the potential relevance of this approach. 🚀 Although more research is needed before this strategy can be translated into patient care, the study offers a new avenue for investigating how we might strengthen the immune system’s response to #cancer. 📖 Read the full study in Nature: nature.com/articles/s41586-0… @hongbo_chi @StJudeResearch @StJude
1
41
1
135
7,496
Ester Gea-Mallorquí retweeted
The personalized neonantigen vaccines to treat cancer, already shown to work in malignant melanoma, and in trials of pancreatic cancer, glioblastoma, renal cell cancer, and triple-negative breast cancer.....now ovarian cancer. Results from a Phase 1 trial nature.com/articles/s41591-0…
15
197
6
692
46,484
Ester Gea-Mallorquí retweeted
1. CRISPR came from basic research on bacteria. 2. Optogenetics started with a discovery in algae. 3. The GFP protein comes from jellyfish. The biggest breakthroughs all trace to scientists follow their curiosity. This is one huge reason why we must keep funding basic research!
52
880
61
4,026
106,295
Ester Gea-Mallorquí retweeted
A remarkable study of 12 million single-cells (RNAseq) from 8 cohorts plus proteomics to determine the immune cells linked to healthy aging. Major findings included: —thymic involution is central (decline in naive T cells and thymic emigrants) —elevated immune system activation, inflammaging —CD8+ memory cells (GZMB+) high frequency —CMV seropositivity and chronic disease @ImmunityCP by @maxim_artyomov and colleagues cell.com/immunity/fulltext/S…
12
71
5
291
32,436
Ester Gea-Mallorquí retweeted
🦉The vaccine got T cells in — but mostly not the ones that mattered. CCL21-engineered dendritic cells did what they were designed to do: they pulled new T-cell clones into resistant NSCLC tumors. Yet among 19 evaluable patients there were no objective responses. The more revealing result came later. Many recruited clones disappeared by day 42, while the minority that persisted were more likely to show tumor-reactive signatures and expanded more strongly in patients with stable disease. Meanwhile, suppressive IL1B⁺/SPP1⁺ macrophage signaling remained. That shifts the bottleneck. In a “cold” tumor, getting more T cells through the door may not be enough. Which clones arrive, whether they recognize tumor, and whether the microenvironment lets them survive may matter more than infiltration itself. Small, uncontrolled phase I data, and tumor specificity was inferred rather than directly proven—but the biology is a useful warning against treating T-cell density as a surrogate for effective immunity. #immunotherapy #T_cell #dendritic_cell 👉doi.org/10.1038/s41467-026-7…
14
1
41
3,236
Ester Gea-Mallorquí retweeted
Embogeixen de felicitat els @cvg_cat, que s'apunten el 3d9f per signar la seva millor actuació de l'any 👏👏👏 #castellsenxarxa #castells #concursTGN2026
22
4
87
8,576
Castellàs 😍 l’enhorabona!
La @collavella fa l'aleta al 3d9 sense folre, el castell més difícil de la història 🩷 Hi ha @concurscastells!!! 🔥🔥🔥 #castellsenxarxa #castells #concursTGN2026
1
6
329
Gràcies a #CastellsenXarxa per agraïr la feinada de les colles internacionals. És una feina ingent, un esforç enorme que projecta la nostra cultura arreu. Avui mirant el concurs des d’Oxford amb @cvg_cat al cor💙
4
23
1,189
Ester Gea-Mallorquí retweeted
A new, engineered #nanobody can target complexes comprising the MHC-I-related protein MR1 and antigens, inhibiting MAIT cell responses to bacteria or driving #antitumor T cell activity. Learn more in Science #Immunology: scim.ag/4h9jgYk
2
12
1
52
3,347
Ester Gea-Mallorquí retweeted
Personalized neoantigen vaccines have already been shown to improve outcomes for refractory malignant melanoma and in pilot studies of pancreatic cancer, glioblastoma, renal cell carcinoma and triple negative breast cancer. But they require a tumor biopsy to identify the antigens. A new study shows it's possible to get this from a blood sample. aacrjournals.org/cancerdisco…
12
62
5
253
34,952
Ester Gea-Mallorquí retweeted
New @ScienceMagazine, a feature The obscure, unsung CD1 branch of our immune system, and how it could be exploited in the future science.org/content/article/…
5
48
2
218
30,520
Ester Gea-Mallorquí retweeted
Replying to @Sciezgin
@Sciezgin lab is on fire! another brilliant collab for us showing that plasma membrane order explains variation among human immune cells that is orthogonal to lineage/differentiation markers: nature.com/articles/s41589-0…
17
1
78
5,627
Ester Gea-Mallorquí retweeted
A new approach to a cancer treatment vaccine 1. Make universal induced pluripotent stem cells into dendritic cells 2. Dress them up with patient's tumor antigens from the membrane of cancer cells that merge with dendritic cells 3. Unleash these cells on T cells to kill tumor sciencedirect.com/science/ar…
25
171
6
562
37,596